IOVA

NASDAQ · Biotechnology

Iovance Biotherapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks

$10.29

+0.10 (+0.98%)

As of Sep 22, 2:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 12 80%

Hold 3 20%

Sell 0 0%

Price Target

Analyst Price Target +432.3% upside

Low Target $41.45

Average Target $54.77

High Target $77.23

Current Price $10.29

Current
$10.29

Target
$54.77

$41.45 $54.77 avg $77.23

Scenario Analysis

Bear Case

$41.45

302.8%

Low target

Base Case

$54.77

+432.3%

Avg target

Bull Case

$77.23

+650.5%

High target

Risk/Reward

2.1x

Favorable

Price in Context

52-Week High

$10.98

-6.3% from high

52-Week Low

$1.76

+484.7% from low

50-Day SMA

$4.30

+139.3% vs SMA

RSI (14)

55.3

Neutral

Target vs 52W High

$54.77

+398.8% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%